Rare diseases
Investigational molecules
Locations
4-10 The Quadrant, OX14 3YS, United Kingdom
Akamis Bio Limited focuses its research efforts on advancing treatment options for patients with solid tumors. The company's therapeutic development programme addresses critical unmet needs in cancer care, with particular emphasis on targeting mechanisms that contribute to tumor growth and progression. Their investigational approach encompasses novel pharmacological strategies designed to interfere with cellular pathways implicated in malignant transformation.
The research portfolio demonstrates commitment to developing innovative molecules that may offer therapeutic benefit to patients with difficult-to-treat malignancies, representing a significant area of clinical investigation for the organization.
Akamis Bio Limited runs clinical trials in conditions such as Neoplasm malignant, Metastatic neoplasm, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
